Director of the Russian Gamaleya Research Center for Epidemiology and Microbiology, Alexander Gintsburg revealed that the cancer vaccine created by the center will be prepared according to each disease case, and with the help of artificial intelligence AI working with high-level Russian software.
“We have prepared an integrated laboratory, and our experts are currently designing high-level artificial intelligence software that will help prepare the vaccine formula,” Novosti news agency quoted Gintsburg as saying on Saturday.
He added “The program that we are waiting for will analyze information about the tumor and develop a plan to formulate the necessary vaccine according to each condition requirement.” Gintsburg pointed out that thanks to artificial intelligence, preparing the vaccine will take a maximum of a week from the beginning of the tumor analysis.
The director of the Gamaleya Center indicated that if this technology could be developed, the vaccine would help patients suffering from non-small cell lung cancer, pancreatic cancer, certain types of kidney cancer, and melanomas.
Russian Health Minister Mikhail Murashko recently announced that preliminary results of pre-clinical studies of the vaccine may be published before the end of the year.
Rawaa Ghanam